APGE Disposition Disclosure
Dambkowski Carl · SEC Form 4 · Filed Sep 3, 2026
Disposition
Calculated transaction value
$185.71K
Dambkowski Carl Chief Medical Officer
APGE
Apogee Therapeutics
APGE
Transaction date
Sep 2, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 1 day later
APGE daily price context
Close on/before transaction
$135.07
Sep 2, 2026
Close before public filing
$135.07
Sep 2, 2026
Return since public filing
0.0%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,375 shares @ $135.06
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001140361-26-035613
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$185.71K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE Current | Disposition | Sep 2, 2026 | $185.71K |